Defining Treatment Response and Symptom Remission for Anxiety Disorders in Pediatric Autism Spectrum Disorders Using the Pediatric Anxiety Rating Scale

Carly J. Johnco, Alessandro S. De Nadai, Adam B. Lewin, Jill Ehrenreich-May, Jeffrey J. Wood, Eric A. Storch

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

This study examined optimal guidelines to assess treatment response and remission for anxiety in youth with autism spectrum disorders (ASD) using the Pediatric Anxiety Rating Scale (PARS). Data was collected for 108 children aged 7–16 years with comorbid anxiety and ASD before and after receiving cognitive behavior therapy. Optimal cut-offs on the PARS were assessed using signal detection analyses using receiver operating characteristic methods. Maximum agreement with response criteria was achieved at 15 % reduction in symptoms on the PARS. Maximum agreement with remission criteria was achieved at 40 % reduction in symptoms, or at a score of 10 or below at post-treatment. Results have implications for standardizing criteria used in research trials and clinical practice.

Original languageEnglish (US)
Pages (from-to)3232-3242
Number of pages11
JournalJournal of Autism and Developmental Disorders
Volume45
Issue number10
DOIs
StatePublished - Oct 22 2015

Keywords

  • Autism
  • Children
  • Measurement
  • Pediatric Anxiety Rating Scale
  • Treatment

ASJC Scopus subject areas

  • Developmental and Educational Psychology

Fingerprint Dive into the research topics of 'Defining Treatment Response and Symptom Remission for Anxiety Disorders in Pediatric Autism Spectrum Disorders Using the Pediatric Anxiety Rating Scale'. Together they form a unique fingerprint.

  • Cite this